investorscraft@gmail.com

Intrinsic ValueSumitomo Bakelite Company Limited (4203.T)

Previous Close¥5,440.00
Intrinsic Value
Upside potential
Previous Close
¥5,440.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Sumitomo Bakelite Company Limited operates as a key player in the specialty chemicals sector, focusing on high-performance materials for semiconductors, industrial applications, and life sciences. The company’s core revenue model is built on manufacturing and selling epoxy resins, phenolic compounds, and advanced plastic products, which are critical for semiconductor encapsulation, medical devices, and functional packaging. Its diversified portfolio serves industries such as automotive, electronics, construction, and healthcare, positioning it as a solutions provider for high-growth technological and industrial demands. With a strong emphasis on R&D, Sumitomo Bakelite maintains a competitive edge in developing innovative materials that meet stringent industry standards, particularly in semiconductor packaging and medical applications. The company’s global footprint and long-standing expertise in resin technologies reinforce its market leadership in niche segments, supported by strategic partnerships and a reputation for reliability in high-specification markets.

Revenue Profitability And Efficiency

Sumitomo Bakelite reported revenue of JPY 287.3 billion for FY 2024, with net income of JPY 21.8 billion, reflecting a steady operational performance. The diluted EPS of JPY 233.66 indicates efficient earnings distribution. Operating cash flow stood at JPY 40.2 billion, while capital expenditures were JPY 21.9 billion, suggesting disciplined reinvestment in growth initiatives. The company’s ability to maintain profitability amid sector-specific challenges underscores its resilient business model.

Earnings Power And Capital Efficiency

The company’s earnings power is demonstrated by its consistent net income and robust operating cash flow, which supports ongoing R&D and market expansion. With a beta of 0.47, Sumitomo Bakelite exhibits lower volatility compared to the broader market, appealing to risk-averse investors. Its capital efficiency is evident in balanced capex and strong liquidity, ensuring sustainable growth without overleveraging.

Balance Sheet And Financial Health

Sumitomo Bakelite maintains a solid balance sheet with JPY 121.6 billion in cash and equivalents, providing ample liquidity. Total debt of JPY 48.5 billion is manageable relative to its market cap of JPY 320 billion, reflecting prudent financial management. The company’s low leverage and high cash reserves position it well to navigate economic uncertainties and fund strategic investments.

Growth Trends And Dividend Policy

The company has shown stable growth, driven by demand for semiconductor materials and life science products. Its dividend per share of JPY 110 highlights a shareholder-friendly approach, balancing reinvestment with returns. Future growth is likely tied to advancements in semiconductor technology and expansion in healthcare markets, supported by its innovative product pipeline.

Valuation And Market Expectations

With a market cap of JPY 320 billion, Sumitomo Bakelite trades at a moderate valuation, reflecting its niche market position and steady earnings. Investors likely value its defensive qualities and exposure to high-growth sectors like semiconductors and medical devices, though broader chemical sector trends may influence performance.

Strategic Advantages And Outlook

Sumitomo Bakelite’s strategic advantages lie in its specialized material expertise, diversified end markets, and strong R&D focus. The outlook remains positive, supported by secular demand for advanced materials in electronics and healthcare. However, macroeconomic headwinds and raw material costs could pose challenges, requiring continued operational agility.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount